VideoHIVINTEREST 2018At the precipice: demographics and the risk of losing control of the HIV epidemic | Mark Dybul, MDView Video
NMMNyaradzo Mavis MgodiMBChB, MMedVideoHIVINTEREST 2018Novel HIV prevention methods for women | Nyaradzo Mgodi, MBChB, MMedView Video
VideoHIVINTEREST 2018The Road to 90-90-90: Progress in HIV prevention and treatment scale-up in sub-Saharan Africa | Karusa Kiragu, PhDView Video
VideoHIVViral Hepatitis and Liver DiseaseInternational Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2018Update on DDI guidelines of the FDA - in vitro | Xinning Yang, PhDView Video
GDPGiovanni Di PerriMD, PhDVideoHIVViral Hepatitis and Liver DiseaseInternational Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2018Clinical Pharmacology of Integrase Inhibitors | Giovanni Di Perri, MD, PhDView Video
ACAndrea CalcagnoMD, DTM&HVideoHIVViral Hepatitis and Liver DiseaseInternational Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2018Last advances in HIV pharmacogenomics | Andrea Calcagno, MD, DTM&HView Video
VideoHIVViral Hepatitis and Liver DiseaseInternational Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2018How/when will pharmacogenomics translate into improved clinical care? | David Haas, MDView Video
VideoHIVViral Hepatitis and Liver DiseaseInternational Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2018Application of Physiologically based pharmacokinetic (PBPK) Modelling to Drug Development Decisions | Joga Gobburu, PhD, MBAView Video
DBDavid BurgerPharmD, PhDVideoHIVViral Hepatitis and Liver DiseaseInternational Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2018The use of DAA’s in pregnancy in HCV infected mothers | David Burger, PharmD, PhDView Video
